Fruit and oats raise risk for type 1 diabetes, but berries may provide protection
TUESDAY, Sept. 10, 2024 (HealthDay News) — Higher consumption of oats, gluten-containing cereals, and fruits by young children is associated with an increased risk for several type 1 diabetes measures, according to a study presented at the annual meeting of the European Association for the Study of Diabetes, held Sept. 9 to 13 in Madrid.
Suvi M. Virtanen, from the Finnish Institute for Health and Welfare in Helsinki, and colleagues examined the associations of food groups and their combinations with islet autoimmunity (IA) and type 1 diabetes risk. The analysis included 5,674 children with genetic susceptibility to type 1 diabetes born from 1996 to 2004, with follow-up to 6 years of age.
The researchers found an increased risk for islet cell antibodies plus biochemical IA with consumption of oats (hazard ratio [HR], 1.09) and banana (HR, 1.07), while cruciferous vegetables (HR, 0.83) were associated with a decreased risk. Additionally, the model for multiple biochemical IA revealed direct associations of fermented dairy (HR, 1.42) and wheat (HR, 1.10). For type 1 diabetes, rye (HR, 1.27), oats (HR, 1.15), and fruits (HR, 1.05) were associated with an increased risk and berries (HR, 0.67) were associated with a decreased risk.
“The rapid increase in type 1 diabetes in children suggests that environmental factors play an important role in the development of the disease,” Virtanen said in a statement. “Identifying these factors will offer an opportunity to develop strategies to prevent it and its complications.”
Maternal Diabetes Linked to Increased Risk for Epilepsy in Offspring
Preexisting Medical Conditions Linked to Range of Botox Injection Complications
Diabetes Linked to Increased Risk for Sudden Cardiac Death
Meta-Analysis IDs Link Between Type 1 Diabetes and Bladder Cancer
Cretostimogene Promising for High-Risk, Non-Muscle-Invasive Bladder Cancer
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine
Perioperative Enfortumab Vedotin + Pembrolizumab Tied to Improved Outcomes With Bladder Cancer
Sex Hormones Linked to Cardiovascular Events in Men With Type 2 Diabetes